Using Mounjaro to Lose 2 Stone: What the Evidence Says

How long does it actually take to lose 2 stone on Mounjaro?

Most people don't lose 2 stone in the first month. That expectation, while understandable, sets an unhelpful baseline. The SURMOUNT-1 trial ran for 72 weeks, and significant weight loss accumulated gradually as doses increased. Early weeks (while you're on the 2.5 mg starter pen) tend to produce modest losses; the bigger shifts typically come as your dose reaches therapeutic levels and your appetite suppression deepens.

A rough working figure: losing half a stone to a stone in the first three months is a reasonable expectation for many people, with losses accelerating as titration progresses. Two stone in six to nine months is plausible for someone responding well at higher doses. If you want a fuller sense of what shorter-term milestones look like, our guide to losing a stone in a month on Mounjaro covers the realistic one-month picture specifically.

Timing matters in practical ways too. Starting treatment at the beginning of the month (before a holiday or around a routine like a Monday order) means your titration schedule aligns with your life rather than fighting it. Your prescriber reviews progress at each repeat, so there's clinical oversight at every step.

Your starting weight shapes the maths more than you might think

Two stone is an absolute number, but percentage weight loss is how the clinical evidence works. If you weigh 16 stone (roughly 102 kg), losing 2 stone is about 12.5% of body weight, well within the range most people on Mounjaro achieve at mid-range doses. If you weigh 11 stone, 2 stone is closer to 18%, which puts it at the upper end of typical outcomes and may take longer or require reaching the maximum dose.

This is one reason the decision about Mounjaro isn't just about the target. A prescriber looks at your BMI, your weight-related health conditions, and what dose trajectory makes sense for you. The Mounjaro overview explains the licensed eligibility criteria in full, but broadly: adults with a BMI of 30 or above, or 27 and above with a qualifying condition such as high blood pressure, high cholesterol, or type 2 diabetes, may be suitable candidates.

NICE's appraisal of tirzepatide (NICE TA1026) recommends it for NHS use in adults with a BMI of 35 or above plus at least one weight-related comorbidity, though private eligibility follows the licensed criteria which are broader.

What affects whether you reach 2 stone, and what doesn't

Mounjaro does the heavy lifting on appetite, but it doesn't override everything. The factors that consistently correlate with stronger results in clinical data include: reaching and maintaining a higher dose, sustaining a modest calorie reduction alongside treatment, prioritising protein to protect muscle mass, and staying active. Our page on getting more from Mounjaro goes into these in practical detail.

What doesn't predict results as cleanly as people assume: sheer willpower, starting a very low-calorie diet from day one, or rushing titration. Forcing a faster dose increase than your body tolerates typically means worse gastrointestinal side effects, which in turn makes it harder to eat adequately and sustain the plan. The full guide to losing weight on Mounjaro covers the lifestyle elements in depth.

Some people lose more than 2 stone. Accounts of losing 3 stone and beyond are well documented, there's a detailed look at what losing 3 stone on Mounjaro involves if that's the territory you're in. Others find 2 stone comes off but progress then slows; that's a clinical conversation about dose, duration, and goals.

Side effects, safety, and the prescription process

The most common side effects are gastrointestinal: nausea, loose stools, constipation, and indigestion feature most often, particularly after starting or after each dose increase. They tend to ease within days to two weeks as your body adjusts. The NHS tirzepatide page lists them clearly and is worth reading before you begin.

A smaller number of people experience more significant reactions. Severe or persistent stomach pain (especially pain that radiates to the back) warrants urgent medical attention, as it can indicate pancreatitis, which the MHRA flagged as an infrequent but serious risk in a Drug Safety Update in January 2026. Anyone with a history of pancreatitis should discuss this with their prescriber before starting.

Mounjaro is not suitable during pregnancy, while breastfeeding, or if you're trying to conceive. It isn't licensed for under-18s. Women taking the oral contraceptive pill should use an additional method for the first four weeks of treatment and for four weeks after each dose increase, as tirzepatide can reduce pill absorption.

The cost of private treatment is worth factoring into your decision early. The Eli Lilly UK price increase in September 2025 raised list prices substantially, and private providers now typically charge between roughly £149 and £375 per month depending on dose and service. One transparent price that includes consultation, prescription, and next-working-day delivery is what to look for.

If you'd like a prescriber to assess whether Mounjaro is suitable for your 2-stone goal, you can speak to our prescribers through a free consultation, reviewed the same day by a real clinician, not an automated system.